An intraosseous myoepithelial carcinoma with a EWSR1::PBX3 fusion von Haglund, Cecilia, Zemmler, Maja, Tsagkozis, Panagiotis, Haglund de Flon, Felix

Volltext

The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center von Renberg, Sara, Zhang, Yifan, Karlsson, Fredrik, Bränström, Robert, Åhlen, Jan, Jalmsell, Li, Linder‐Stragliotto, Christina, Haglund de Flon, Felix, Papakonstantinou, Andri

Volltext

Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy von Berndsen, Marta, Renberg, Sara, Hølmebakk, Toto, Hancke, Emma, Puls, Florian, Karlsson, Fredrik, Stoldt, Stephan, Bjerkehagen, Bodil, Haglund de Flon, Felix, Muth, Andreas, Papakonstantinou, Andri, Boye, Kjetil, Lindskog, Stefan

Volltext

Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8+ T cells towards the center of human lung tumors von Brownlie, Demi, von Kries, Andreas, Valenzano, Giampiero, Wild, Nicole, Yilmaz, Emel, Säfholm, Jesper, Al-Ameri, Mamdoh, Alici, Evren, Ljunggren, Hans-Gustaf, Schliemann, Igor, Aricak, Ozan, Haglund de Flon, Felix, Michaëlsson, Jakob, Marquardt, Nicole

Volltext

1381P TOGETHER: Pooled real-world datasets of METex14 skipping NSCLC and adjusted comparison of upfront (chemo-)immunotherapy with tepotinib from VISION von Christopoulos, P., Ekman, S., Guisier, F., Ho, C., Blasi, M., Brunnstrom, H., Cvetkovic, J., Kazdal, D., Kuon, J.B., Haglund de Flon, F., Stenzinger, A., Wong, S., Hatswell, A., McLean, T., Bergman, S., Orlowski, K., OBrate Grupp, A.M., Vioix, H., Thomas, M.

Volltext

58P Evaluating the impact of WGTS in routine diagnostics of bone and soft tissue tumors von Wallander, K.M., Öfverholm, I., Yingbo, L., Haglund, C., Chellappa, V., Tsagkozis, P., Hesla, A., Papakonstantinou, A., Bränström, R., Wirta, V., Lindberg, J., Haglund de Flon, F.

Volltext

Sarcoma care in the era of precision medicine von Wallander, Karin, Öfverholm, Ingegerd, Boye, Kjetil, Tsagkozis, Panagiotis, Papakonstantinou, Andri, Lin, Yingbo, Haglund de Flon, Felix

Volltext

EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma von Mushtaq, Muhammad, Liaño-Pons, Judit, Wang, Jiansheng, Alzrigat, Mohammad, Yuan, Ye, Ruiz-Pérez, María Victoria, Chen, Yi, Kashuba, Elena, Haglund de Flon, Felix, Brodin, Bertha, Arsenian-Henriksson, Marie

Volltext

Diagnosing gastrointestinal stromal tumors: The utility of fine‐needle aspiration cytology versus biopsy von Zhang, Yifan, Renberg, Sara, Papakonstantinou, Andri, Haglund de Flon, Felix

Volltext

Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals von Skribek, Marcus, Brunnström, Hans, Oskarsdottir, Gudrun, Portu Grivé, Mikel, Aricak, Ozan, Planck, Maria, Jatta, Kenbugul, Naserhojati, Homeyra, Haglund de Flon, Felix, Ekman, Simon

Volltext

Molecular Profiling Defines Three Subtypes of Synovial Sarcoma von Chen, Yi, Su, Yanhong, Cao, Xiaofang, Siavelis, Ioannis, Leo, Isabelle Rose, Zeng, Jianming, Tsagkozis, Panagiotis, Hesla, Asle C., Papakonstantinou, Andri, Liu, Xiao, Huang, Wen‐Kuan, Zhao, Binbin, Haglund, Cecilia, Ehnman, Monika, Johansson, Henrik, Lin, Yingbo, Lehtiö, Janne, Zhang, Yifan, Larsson, Olle, Li, Xuexin, de Flon, Felix Haglund

Volltext

Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics? von Ameline, Baptiste, Nathrath, Michaela, Nord, Karolin H., de Flon, Felix Haglund, Bovée, Judith V.M.G., Krieg, Andreas H., Höller, Sylvia, Hench, Jürgen, Baumhoer, Daniel

Volltext

CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma von Saba, Karim H., Difilippo, Valeria, Styring, Emelie, Nilsson, Jenny, Magnusson, Linda, van den Bos, Hilda, Wardenaar, René, Spierings, Diana C. J., Foijer, Floris, Nathrath, Michaela, Haglund de Flon, Felix, Baumhoer, Daniel, Nord, Karolin H.

Volltext

Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation von Xagoraris, Ioanna, Stathopoulou, Konstantina, Aulerio, Roberta D', He, Minghui, Ketscher, Anett, Jatta, Kenbugul, de Flon, Felix Haglund, Barbany, Gisela, Rosenquist, Richard, Westerberg, Lisa S., Rassidakis, George Z.

Volltext